AASLD/NASPGHAN, Part 1: Immune-Mediated Pediatric Liver Disease—From Phenotype to Precision Therapy
Nov
2026
Description
The diagnosis and management of autoimmune hepatitis in children have remained largely unchanged for decades. Jointly planned by the American Association for the Study of Liver Diseases and the North American Society for Pediatric Gastroenterology, Hepatology, and Nutrition, this informative session highlights advances in immunophenotyping and biomarker discovery, and explores emerging approaches to the management of refractory disease, and autoimmune hepatitis in special pediatric populations.
Presentations
8:00 AM
- 8:18 AM
Convention Center - Bluebird Ballroom 3DEF
Beyond Autoantibodies: Novel Biomarkers and Immunophenotyping in Pediatric Autoimmune and Indeterminate Severe Hepatitis
Estella M Alonso, MD, FAASLD | Presenter
8:18 AM
- 8:36 AM
Convention Center - Bluebird Ballroom 3DEF
Refractory Autoimmune Hepatitis in Children: Redefining Treatment Beyond Steroids and Azathioprine
Saeed Mohammad | Presenter
8:36 AM
- 8:54 AM
Convention Center - Bluebird Ballroom 3DEF
Autoimmune Hepatitis in Special Populations: Overlap Syndromes, Immune Dysregulation, and Posttransplant Disease
Lorenzo D'Antiga, MD | Presenter
8:54 AM
- 9:12 AM
Convention Center - Bluebird Ballroom 3DEF
Quality Measures for Immune Liver Diseases: What Should We Be Targeting?
Amy E Taylor, MD | Presenter
